We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Insurance-based Disparities in Gastro-Entero-Pancreatic Neuroendocrine Tumor Patients.
- Authors
Baechle, Jordan J
- Abstract
In the United States, uninsurance remains a major barrier in accessing health care for many citizens and residents. Studies have shown that uninsured patients with many cancers and chronic diseases have worse survival than insured patients. A recent study similarly showed that uninsured patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) have significantly shortened survival. While GEP-NETs are indolent tumors with generally favorable prognosis, comprehensive care involves years of surveillance, imaging, and treatment following resection, all of which carry a large financial burden. In this commentary, we expand on these findings as they relate to insurance-based disparities as well as management and policy implications.
- Subjects
UNITED States; MEDICAL care costs; PANCREATIC tumors; HEALTH policy; HEALTH services accessibility; LIVER tumors; HEALTH status indicators; NEUROENDOCRINE tumors; COVID-19 pandemic; ECONOMICS
- Publication
Journal of Health Care for the Poor & Underserved, 2021, Vol 32, Issue 3, p1
- ISSN
1049-2089
- Publication type
Article